Yaeger OC, Diermissen ME

Language: Spanish
References: 8
Page: 143-145
PDF size: 22.85 Kb.

ABSTRACT

Migraine is a prevalent condition in young, otherwise healthy people, with a minimal number of patients receiving appropriate preventative therapy. Preventative treatment with daily medication is necessary for patients who have two or more attacks per week or whose attacks respond poorly to abortive medication. Often multiple agents providing different mechanisms of action may be needed. It is essential that patients use their acute medication even when on prophylaxis but Iess than two times per week on an ongoing basis. It is imperative to be patient with preventative outcome because it can take weeks to establish.

REFERENCES

1. Brandes JL, Saper JR, Diamond M et al, Topiramate for migraine prevention a randomized controlled trial. JAMA 2004; 291: 965-73.

2. Graff-Radford, Steven. Migraine Prophylaxis. Clin Fam Practice 2005; 7: 445-462.

3. Headache Consortium. American Academy of Neurology Headache Guidelines. Available at: http://www.aan.com/professionals/practiceguidelines/index.cfm (accessed November 15, 2006).

4. Lipton RB, Diamond S. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001: 41: 638-45.

5. Loder, Elizabeth. Migraine diagnosis and treatment. Prim Care Clin Office Pract 2004; 31: 277-292.

6. Ravishankar, Nandini; Demakis, George. The Neuropsychology of Migraine. Dis Mon 2007; 53: 156-161.

7. Silverstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. 2nd Edition. New York: Martin Dunitz; 2002.

8. Snow V, Weiss K, Wall EM, Mottor PC. For the American Academy of Family Physicians and the American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002; 137: 840-9.Z